Basal Insulin Adherence in Patients with Type 2 Diabetes Mellitus in Routine Clinical Practice in Spain: Clinical and Economic Impact

Dídac Mauricio, Virginia Pascual, Maria Soler, Francisco J Pérez-Sádaba · 2026

Read Basal Insulin Adherence in Patients with Type 2 Diabetes Mellitus in Routine Clinical Practice in Spain: Clinical and Economic Impact by Dídac Mauricio, Virginia Pascual, Maria Soler, Francisco J Pérez-Sádaba (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13457819.txt.

Description

Dídac Mauricio and colleagues measure how faithfully Spanish patients with type 2 diabetes take their long-acting basal insulin, and what lapses cost. Their 2026 retrospective study mined the THIN primary-care database for 9,441 adults whose first basal insulin prescription dated from 2014, following prescription and dispensing records across a decade. Adherence meant covering at least 80 percent of days.

Fewer than seven in ten patients qualified as adherent: 66.90 percent in the full group and 69.51 percent among those followed three years or more. Adherent patients skewed older and more often retired, yet the groups otherwise looked alike. Complications were common in both, and non-adherent patients accumulated them faster year by year. Annual complication costs averaged about 1,307 euros for the non-adherent against 1,092 for the adherent, with total direct and indirect costs also higher. The authors call adherence an unmet need that quietly taxes the health system.

Catalog record

CREATORDídac Mauricio, Virginia Pascual, Maria Soler, Francisco J Pérez-Sádaba
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE33930
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13457819

Browse the full library · About the Tower of Babel